Dialysis With CARPEDIEM®: French Multicentric Experience in 25 Patients
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 25
- 试验地点
- 1
- 主要终点
- Serum potassium
研究概览
简要总结
Historically, CKRT and hemodialysis were performed in small infants and newborns with devices developed for adults with high rates of complications and mortality.
We aim to retrospectively report the first multicenter French experience of CARPEDIEM® use and evaluate the efficacy, feasibility, outcomes, and technical considerations of this new device in a population of neonates and small infant. Compared to adult's device continuous renal replacement therapy with an adapted machine allowed successful blood purification without severe complications even in low birth weight neonates.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 0 Years 至 3 Years(Child)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- •Renal replacement therapy with another device than Carpediem machine
结局指标
主要结局
Serum potassium
时间窗: 3 years
Survival
时间窗: 3 years
Serum creatinine
时间窗: 3 years
Blood urea nitrogen
时间窗: 3 years
Ammonia levels
时间窗: 3 years
次要结局
- Ultrafiltration flow(3 years)
- Time of treatments(3 years)
- Number of sessions(3 years)
- Vascular access(3 years)
- Priming circuit(3 years)
- Blood flow(3 years)
- Anticoagulation(3 years)
- Size of the circuit(3 years)
- Death(3 years)
- CKRT modality(3 years)
- Clotting circuit and other dysfunction circuit(3 years)
